Answers are grounded in this paper and cite their sources.
The list of cell surface receptors crosslinking with the c-MET signaling is constantly growing, highlighting the importance of this pathway for personalized target therapy. Research on the combination of c-MET inhibitors with other drugs will hopefully lead to discovery of new effective treatment options.
No takes yet. Share an insight, caveat, or question.
Faiella et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: